MedTrace Logo

Quell Opioid Reduction and Pain Relief in Patients With Cancer

NCT02809846 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-01-21

Study results available
· View outcomes & findings →

Summary

To study effects the Quell device has on opioid consumption and pain relief in patients with cancer.

Conditions

Interventions

DEVICE

Quell

DEVICE

Sham Quell

Sponsors & Collaborators

  • NeuroMetrix, Inc.

    collaborator INDUSTRY

  • Scripps Translational Science Institute

    lead OTHER

Principal Investigators

  • Lase Ajayi, MD · Scripps

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-08-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02809846 on ClinicalTrials.gov